THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,271,466 | -16.2% | 857,386 | -11.4% | 0.00% | 0.0% |
| Q1 2024 | $8,678,893 | -22.3% | 967,452 | -2.7% | 0.00% | 0.0% |
| Q4 2023 | $11,173,535 | +22.0% | 994,000 | -6.3% | 0.00% | 0.0% |
| Q3 2023 | $9,158,782 | -24.1% | 1,061,177 | -9.0% | 0.00% | 0.0% |
| Q2 2023 | $12,064,608 | -6.2% | 1,165,662 | -1.7% | 0.00% | -50.0% |
| Q1 2023 | $12,868,205 | +100440.7% | 1,186,009 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $12,799 | -99.9% | 1,140,753 | +5.7% | 0.00% | 0.0% |
| Q3 2022 | $10,941,000 | +17.5% | 1,079,087 | +5.0% | 0.00% | +100.0% |
| Q2 2022 | $9,310,000 | -3.6% | 1,027,664 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $9,657,000 | -16.1% | 1,010,163 | -3.0% | 0.00% | 0.0% |
| Q4 2021 | $11,512,000 | +123.7% | 1,041,832 | +49.8% | 0.00% | 0.0% |
| Q3 2021 | $5,146,000 | -62.0% | 695,504 | -25.4% | 0.00% | -50.0% |
| Q2 2021 | $13,536,000 | -20.9% | 932,268 | +11.2% | 0.00% | -33.3% |
| Q1 2021 | $17,110,000 | +27.6% | 838,363 | +11.1% | 0.00% | +50.0% |
| Q4 2020 | $13,407,000 | +22.9% | 754,485 | +2.2% | 0.00% | 0.0% |
| Q3 2020 | $10,912,000 | -27.9% | 738,095 | +2.3% | 0.00% | -33.3% |
| Q2 2020 | $15,142,000 | -8.9% | 721,433 | +0.3% | 0.00% | -25.0% |
| Q1 2020 | $16,617,000 | -47.5% | 719,072 | -41.2% | 0.00% | +33.3% |
| Q4 2019 | $31,654,000 | +165.4% | 1,222,696 | +99.7% | 0.00% | 0.0% |
| Q3 2019 | $11,929,000 | +24.7% | 612,399 | +4.6% | 0.00% | +50.0% |
| Q2 2019 | $9,565,000 | -22.4% | 585,741 | +7.7% | 0.00% | -33.3% |
| Q1 2019 | $12,333,000 | -51.5% | 544,029 | -45.3% | 0.00% | -25.0% |
| Q4 2018 | $25,446,000 | +72.6% | 994,448 | +120.4% | 0.00% | 0.0% |
| Q3 2018 | $14,741,000 | +49.5% | 451,221 | +3.8% | 0.00% | +33.3% |
| Q2 2018 | $9,859,000 | +3.5% | 434,721 | +10.6% | 0.00% | 0.0% |
| Q1 2018 | $9,530,000 | -8.5% | 393,009 | +5.2% | 0.00% | -25.0% |
| Q4 2017 | $10,416,000 | -15.6% | 373,476 | +3.7% | 0.00% | -20.0% |
| Q3 2017 | $12,335,000 | -12.4% | 360,259 | +1.9% | 0.01% | -16.7% |
| Q2 2017 | $14,085,000 | +15.8% | 353,550 | +7.0% | 0.01% | +20.0% |
| Q1 2017 | $12,160,000 | +22.2% | 330,280 | +5.8% | 0.01% | 0.0% |
| Q4 2016 | $9,949,000 | +3.2% | 312,103 | +17.3% | 0.01% | 0.0% |
| Q3 2016 | $9,639,000 | +73.0% | 266,000 | +8.3% | 0.01% | +66.7% |
| Q2 2016 | $5,571,000 | +53.4% | 245,586 | +27.1% | 0.00% | +50.0% |
| Q1 2016 | $3,632,000 | +24.6% | 193,239 | +8.6% | 0.00% | 0.0% |
| Q4 2015 | $2,915,000 | +56.9% | 177,899 | +5.1% | 0.00% | +100.0% |
| Q3 2015 | $1,858,000 | -11.9% | 169,201 | +4.5% | 0.00% | 0.0% |
| Q2 2015 | $2,108,000 | -11.2% | 161,973 | +18.3% | 0.00% | 0.0% |
| Q1 2015 | $2,375,000 | +17.9% | 136,904 | +1.3% | 0.00% | 0.0% |
| Q4 2014 | $2,015,000 | -33.7% | 135,087 | +2.5% | 0.00% | -50.0% |
| Q3 2014 | $3,037,000 | -26.6% | 131,760 | +1.5% | 0.00% | -33.3% |
| Q2 2014 | $4,139,000 | – | 129,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foundation Asset Management, LP | 933,881 | $13,934,000 | 3.34% |
| Baupost Group | 6,061,228 | $90,434,000 | 1.78% |
| Clearline Capital LP | 250,550 | $3,738,000 | 0.58% |
| Rock Springs Capital Management LP | 290,000 | $4,327,000 | 0.51% |
| Roundview Capital LLC | 41,917 | $625,000 | 0.26% |
| Old West Investment Management, LLC | 19,811 | $295,000 | 0.18% |
| HighVista Strategies LLC | 86,700 | $1,294,000 | 0.17% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 296,234 | $4,420,000 | 0.17% |
| FIRST MANHATTAN CO. LLC. | 1,446,960 | $21,588,000 | 0.12% |
| REINHART PARTNERS, LLC. | 71,850 | $1,072,000 | 0.08% |